Announcement on Results of Share Reduction by Director
Filed with SSE · · 3 pages · Chinese
Summary by 6ix AI
Aurisco Pharmaceutical Co. Ltd. has announced the results of a share reduction by a director. Director Chu Yizhou reduced his holdings by a specific number of shares, completing the planned reduction. The announcement confirms that the reduction was executed in compliance with relevant regulations.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Aurisco Pharmaceutical Co. Ltd. on 6ix
Earlier from Aurisco Pharmaceutical
- Announcement on the Company Certified as High-tech Enterprise
- Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares Reaching 1% Scale
- Announcement on Shareholding Reduction Plan for Partial Board of Directors
- Announcement on Implementation Result of Shares Repurchase and Share Changes
- Announcement on Adjusting Upper Limit of Repurchase Price
Later from Aurisco Pharmaceutical
- Announcement on Conversion Result of Convertible Bonds and Share Changes
- Announcement on the Estimated External Guarantee Limit
- Report for Q1 2026
- Announcement on Resolutions of the 1st Meeting of the 4th Board of Directors
- Announcement on Obtaining Drug Registration Approval by the Company
Follow Aurisco Pharmaceutical into a list and get an email when it puts out news.
Follow Aurisco Pharmaceutical